Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Dendreon

Dendreon
1992 FOUNDED
M&A STATUS
701-800 EMPLOYEES
M&A LATEST DEAL TYPE
19 FINANCING ROUNDS
1 INVESTMENTS
Description

Developer of personalized immune-therapeutics for cancer. The company is focused towards discovery, development, commercialization, and manufacturing of immunotherapy product candidates for the potential treatment of a variety of cancers, providing treatments that are clinically proven to help extend the lives of patients battling cancer.

Formerly Known As
Activated Cell Therapy
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 1700 Saturn Way
  • Seal Beach, CA 90740
  • United States

+1 (877) 000-0000

Dendreon Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Dendreon‘s full profile, request access.

Request full access to PitchBook

Dendreon Competitors (35)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immatics Venture Capital-Backed Tübingen, Germany 000 00000 00000000000 00000
0000000 0000000000 Venture Capital-Backed Indianapolis, IN 00 000.00 0000000000 0 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
00000000 Formerly VC-backed Munich, Germany 000.00 000000&0 000.00
00000 000000000000 Formerly VC-backed New York, NY 00 000.00 000000000000 000.00
To view this company’s complete list of competitors, request access »

Dendreon Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 30-Jul-2003 000000000000000000 0000 Biotechnology 00000000 0000 00
To view this company’s complete investment and acquisition history, request access »

Dendreon Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Dendreon‘s full profile, request access.

Request full access to PitchBook

Dendreon Executive Team (14)

Name Title Board
Seat
Contact
Info
Thomas Amick President, Chief Executive Officer & Board Member
Silvio Pacheco Chief Customer Officer
Andrew Sandler MD Executive Vice President, Research & Development & Chief Medical Officer

11 Former Executives

You’re viewing 3 of 14 executives. Get the full list »

Dendreon Board Members (8)

Name Representing Role Since Contact
Info
0000000 000000 Dendreon Chairman 000 0000
000000 00000 Dendreon President, Chief Executive Officer & Board Member 000 0000

6 Former Board Members

You’re viewing 2 of 8 board members. Get the full list »